Healthcare provider profile · identity verified

Joel Farris, AGNP

Nurse Practitioner · DALLAS, TX · NPI 1487133021

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	544	81
Atorvastatin Calcium	Atorvastatin Calcium	414	71
Potassium Chloride	Potassium Chloride	408	65
Sertraline Hcl	Sertraline Hcl	407	60
Gabapentin	Gabapentin	325	50
Amlodipine Besylate	Amlodipine Besylate	324	49
Quetiapine Fumarate	Quetiapine Fumarate	314	43
Pantoprazole Sodium	Pantoprazole Sodium	295	46
Lisinopril	Lisinopril	293	42
Torsemide	Torsemide	293	41
Trazodone Hcl	Trazodone Hcl	269	51
Donepezil Hcl	Donepezil Hcl	265	46
Memantine Hcl	Memantine Hcl	265	43
Mirtazapine	Mirtazapine	254	37
Metoprolol Succinate	Metoprolol Succinate	249	41
Losartan Potassium	Losartan Potassium	218	34
Eliquis	Apixaban	195	36
Furosemide	Furosemide	195	38
Montelukast Sodium	Montelukast Sodium	161	28
Fluoxetine Hcl	Fluoxetine Hcl	158	27
Escitalopram Oxalate	Escitalopram Oxalate	155	31
Rosuvastatin Calcium	Rosuvastatin Calcium	147	22
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	142	20
Tamsulosin Hcl	Tamsulosin Hcl	135	20
Metoprolol Tartrate	Metoprolol Tartrate	122	21
Pravastatin Sodium	Pravastatin Sodium	122	14
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	106	74
Hydralazine Hcl	Hydralazine Hcl	103	23
Clopidogrel	Clopidogrel Bisulfate	101	18
Omeprazole	Omeprazole	99	19
Metformin Hcl	Metformin Hcl	97	18
Duloxetine Hcl	Duloxetine Hcl	94	14
Hydrochlorothiazide	Hydrochlorothiazide	92	15
Simvastatin	Simvastatin	87	14
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	85	12
Xarelto	Rivaroxaban	81	suppressed
Divalproex Sodium	Divalproex Sodium	77	15
Famotidine	Famotidine	75	13
Carvedilol	Carvedilol	73	12
Prednisone	Prednisone	72	38
Doxycycline Hyclate	Doxycycline Hyclate	71	51
Methenamine Hippurate	Methenamine Hippurate	71	12
Fluticasone Propionate	Fluticasone Propionate	69	20
Meloxicam	Meloxicam	69	11
Ondansetron Hcl	Ondansetron Hcl	67	52
Finasteride	Finasteride	62	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	59	suppressed
Paroxetine Hcl	Paroxetine Hcl	59	suppressed
Olanzapine	Olanzapine	58	suppressed
Myrbetriq	Mirabegron	53	14
Citalopram Hbr	Citalopram Hydrobromide	48	13
Alprazolam	Alprazolam	47	suppressed
Loperamide	Loperamide Hcl	46	26
Pregabalin	Pregabalin	46	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	43	19
Rivastigmine	Rivastigmine	43	suppressed
Spironolactone	Spironolactone	43	11
Cefdinir	Cefdinir	42	35
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	34
Digoxin	Digoxin	40	suppressed
Gemtesa	Vibegron	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Risperidone	Risperidone	37	suppressed
Liothyronine Sodium	Liothyronine Sodium	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	27
Azelastine Hcl	Azelastine Hcl	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Methocarbamol	Methocarbamol	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	31	15
Terazosin Hcl	Terazosin Hcl	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	15
Valsartan	Valsartan	31	suppressed
Lorazepam	Lorazepam	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Latanoprost	Latanoprost	27	suppressed
Linzess	Linaclotide	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Atenolol	Atenolol	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Fluconazole	Fluconazole	25	17
Estradiol	Estradiol	24	suppressed
Alendronate Sodium	Alendronate Sodium	23	suppressed
Nystatin	Nystatin	23	16
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Spiriva Handihaler	Tiotropium Bromide	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Propafenone Hcl	Propafenone Hcl	20	suppressed
Raloxifene Hcl	Raloxifene Hcl	20	suppressed
Levemir Flexpen	Insulin Detemir	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Topiramate	Topiramate	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Bumetanide	Bumetanide	18	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Azithromycin	Azithromycin	17	16
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Baclofen	Baclofen	15	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Modafinil	Modafinil	13	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	13	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Megestrol Acetate	Megestrol Acetate	11	suppressed
Nystop	Nystatin	11	suppressed
Ramipril	Ramipril	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error